Search results
The National University Cancer Institute, Singapore is a national specialist centre under the National University Health System that treats both paediatric and adult cancers.
- Appointments
Appointments - NCIS | National University Cancer Institute,...
- Find Directions
By MRT Train. Step 1: Alight at the Kent Ridge MRT station...
- Our Facilities
breast_surgery@nuhs.edu.sg. Location NUH Medical Centre,...
- What to Expect For Your First Visit
What to Expect For Your First Visit - NCIS | National...
- TeleConsult
NCIS Honour Roll of Donors. Donating to Research....
- Total Bill Estimates & Benchmarks
The NCIS team partners the National University Hospital...
- Overseas Referral
We recognise that foreign patients who seek medical...
- Home & Community Programmes
NCIS Home & Community Services Page Content To provide...
- Appointments
The National University Cancer Institute, Singapore (NCIS) is a national specialist centre under the National University Health System (NUHS). It is the only public cancer centre in Singapore treating both paediatric and adult cancers in one facility.
Singapore 119074 . Opening Hours: 8.30am to 5.30pm (Mondays - Fridays) Closed on Weekends & Public Holidays . Website: http://www.ncis.com.sg
The National Childhood Immunisation Schedule (NCIS) comprises childhood vaccinations recommended as the standard of care for protection against vaccine preventable diseases that are of significant healthcare burden to Singapore or would be so without these vaccinations.
National Childhood Immunisation Schedule (NCIS) (From birth to age 17 years, effective from 1 November 2020) One or two doses for children and adolescents age 2-17 years with specific medical condition or indication. 6 months to <5 years (6-59 months). adolescents age 5-17 years with specific medical condition or indication. 6 months to <5 ...
National Childhood Immunisation Schedule (NCIS) (from birth to age 17 years, effective from 1 November 2020) Vaccine Birth 2 months 4 Months 6 months 12 months 15 months 18 months 2-4 years 5-9 years 10-11 years 12-13 years 13-14 years 15-17 years Bacillus Calmette-Guérin (BCG) D1 Hepatitis B (HepB)
NCIS will be beginning the first-in-human trial for CAR-T cell therapy using cells from healthy donors. One of the most remarkable and promising cancer treatments in recent years, the trial will test new therapy on patients with lymphoma, multiple myeloma, colorectal, lung, liver or ovarian cancer.